Accepting New Patients
Accepting New Patients
Andrew E. Hendifar, MD
4.9
66 Reviews
310-423-2217
Fax: 310-967-8486
4.9
66 Reviews
Andrew E. Hendifar, MD
Scheduling
In person visits
Fax: 310-967-8486
Samuel Oschin Cancer Center
127 S San Vicente Blvd - 7th Floor
Los Angeles, CA
34.074713 -118.379418From You
4.9
66 Reviews
Accepting New Patients
Andrew E. Hendifar, MD
Languages
- English,
- Spanish,
Gender
Male
Experience
19 Years
Locations
Samuel Oschin Cancer Center
Samuel Oschin Cancer Center
-
Self-parking is available in Cedars-Sinai parking lot P4. The cost is: 1st hour free, $5 each hour thereafter and $15 daily maximum. Valet parking is the same price as self-parking. Gratuities are not accepted. Valet is available at lot P4 Pavilion M-F, 5 a.m.-10 p.m.
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- IM Hematology Oncology
Programs
Cedars-Sinai clinical programs this provider is part of:
7
Research Areas
Titles
- Medical Director, Pancreatic Cancer
- Co-Director, Hematology/Oncology Fellowship Program
- Associate Professor of Medicine, Cedars-Sinai
Education & Training
-
University of Southern California
Fellowship - Completed 2010
-
Los Angeles County + USC Medical Center
Residency - Completed 2007
-
Los Angeles County + USC Medical Center
Internship - Completed 2006
-
Tulane University School of Medicine
Medical School - Completed 2003
Achievements
-
2
Board Certifications
-
7
Awards and Honors
-
6
Publications
Board Certifications
-
IM/Hematology
American Board of Internal Medicine
-
IM/Oncology
American Board of Internal Medicine
Awards and Honors
- Super Doctors
- Member, Neuroendocrine Tumors Task Force (NET TF) of the National Cancer Institute (NCI) Gastrointestinal Steering Committee
- Steering Committee Member, Precision Promise Clinical Trial Consortium
- Course Director, LACNETS & CFCF Annual Neuroendocrine Tumor Patient & Caregiver Educational Conference
- Course Director, Gastrointestinal Cancer Conference
- Supportive Care Medicine Chair, Precision Promise Consortium, Pancreatic Cancer Action Network
- Editorial Board: Journal of Pancreatology
Publications
- Hingorani SR, Zheng L, Bullock AJ, Seery TE, Harris WP, Sigal DS, Braiteh F, Ritch PS, Zalupski MM, Bahary N, Oberstein PE, Wang-Gillam A, Wu W, Chondros D, Jiang P, Khelifa S, Pu J, Aldrich C, Hendifar AE. HALO 202: Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine versus nab-paclitaxel/gemcitabine in patients with untreated, metastatic pancreatic ductal adenocarcinoma. J Clin Oncol. 2018 Feb 1;36(4):359-366. doi: 10.1200/JCO.2017.74.9564. Epub 2017 Dec 12. PubMed PMID: 29232172.
- Hendifar AE, Chang JI, Huang BZ, Tuli R, Wu BU. Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy. J Gastrointest Oncol. 2018 Feb;9(1):17-23. doi: 10.21037/jgo.2017.11.10. PubMed PMID: 29564167; PubMed Central PMCID: PMC5848037.
- Strosberg J, Wolin E, Chasen B, Kulke M, Bushnell D, Caplin M, Baum RP, Kunz P, Hobday T, Hendifar A, Oberg K, Sierra ML, Thevenet T, Margalet I, Ruszniewski P, Krenning E; NETTER-1 Study Group. Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with (177)Lu-Dotatate in the phase III NETTER-1 trial. J Clin Oncol. 2018 Jun 7:JCO2018785865. doi: 10.1200/JCO.2018.78.5865. [Epub ahead of print] PubMed PMID: 29878866.
- Singhi AD, Ali SM, Lacy J, Hendifar A, Nguyen K, Koo J, Chung JH, Greenbowe J, Ross JS, Nikiforova MN, et al. Identification of targetable ALK rearrangements in pancreatic ductal adenocarcinoma. J Natl Compr Canc Netw. 2017 May;15(5):555-562. PubMed PMID: 28476735.
- Hendifar A, Osipov A, Khanuja J, Nissen N, Naziri J, Yang W, Li Q, Tuli R. Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma. PLoS One. 2016 Mar 25;11(3):e0152172.
- Khanuja J, Gresham G, Osipov A, Tuli R, Hendifar A. Treatment and underlying mechanisms of pancreatic cancer cachexia (PANCAX study). J Clin Oncol. 2015;33.
Insurances
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Cedars-Sinai location or provider is included in your network.